Jan 11, 2016 12:00 pm UTC| Business
SAINT-GENIS-POUILLY, France, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear medicine, today announced an...
Ekso Bionics Announces New Clinical Trial Underway in Europe
Jan 11, 2016 12:00 pm UTC| Business
RICHMOND, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a leading global robotic exoskeleton company, announced a new randomized comparative clinical trial is currently underway in...
Jan 11, 2016 12:00 pm UTC| Business
NEW YORK, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Sotheby’s (NYSE:BID) today announced that it has acquired the art advisory firm Art Agency, Partners (AAP), managed by Amy Cappellazzo, Allan Schwartzman, and Adam Chinn. With...
Cyclacel Reviews 2015 Achievements and Announces Key Business Objectives for 2016
Jan 11, 2016 12:00 pm UTC| Business
BERKELEY HEIGHTS, N.J., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company) today reviewed 2015 achievements and provided an outline of the Company's...
Jan 11, 2016 12:00 pm UTC| Business
CHICAGO, Jan. 11, 2016 (GLOBE NEWSWIRE) -- In the spirit of Dr. Martin Luther King, Jr. Day (Monday, Jan. 18), CheapTickets.com®, a leading seller of discounted travel products, has identified five historic U.S....
ICA Fluor to Build a US$1 Billion Dollar Refining Facility in Mexico
Jan 11, 2016 12:00 pm UTC| Business
MEXICO CITY, Jan. 11, 2016 (GLOBE NEWSWIRE) -- ICA Fluor, the industrial construction joint venture of Empresas ICA, S.A.B. de C.V. (BMV:ICA) and (NYSE:ICA) and Fluor Corporation (NYSE:FLR), announced today that its ICA...
Anavex Announces Positive Dose-Response Data for ANAVEX 2-73 in Alzheimer's Disease Patients
Jan 11, 2016 12:00 pm UTC| Business
NEW YORK, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of...